Addex Therapeutics (ADXN) Operating Leases: 2022-2025
Historic Operating Leases for Addex Therapeutics (ADXN) over the last 3 years, with Jun 2025 value amounting to $37,319.
- Addex Therapeutics' Operating Leases rose 70.53% to $37,319 in Q2 2025 from the same period last year, while for Jun 2025 it was $37,319, marking a year-over-year increase of 70.53%. This contributed to the annual value of $47,735 for FY2024, which is 87.55% down from last year.
- According to the latest figures from Q2 2025, Addex Therapeutics' Operating Leases is $37,319, which was up 2.28% from $36,486 recorded in Q1 2025.
- Addex Therapeutics' Operating Leases' 5-year high stood at $388,189 during Q4 2023, with a 5-year trough of $21,884 in Q2 2024.
- Moreover, its 3-year median value for Operating Leases was $38,300 (2025), whereas its average is $80,822.
- In the last 5 years, Addex Therapeutics' Operating Leases crashed by 87.65% in 2024 and then soared by 70.53% in 2025.
- Over the past 4 years, Addex Therapeutics' Operating Leases (Quarterly) stood at $387,322 in 2022, then climbed by 0.22% to $388,189 in 2023, then plummeted by 87.65% to $47,937 in 2024, then spiked by 70.53% to $37,319 in 2025.
- Its Operating Leases stands at $37,319 for Q2 2025, versus $36,486 for Q1 2025 and $47,937 for Q4 2024.